These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 33724652)

  • 1. ARL4C might serve as a prognostic factor and a novel therapeutic target for gastric cancer: bioinformatics analyses and biological experiments.
    Xie N; Bai Y; Qiao L; Bai Y; Wu J; Li Y; Jiang M; Xu B; Ni Z; Yuan T; Shi Y; Wu K; Xu F; Wang J; Dong L; Liu N
    J Cell Mol Med; 2021 Apr; 25(8):4014-4027. PubMed ID: 33724652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of ARL4C as a Peritoneal Dissemination-Associated Gene and Its Clinical Significance in Gastric Cancer.
    Hu Q; Masuda T; Sato K; Tobo T; Nambara S; Kidogami S; Hayashi N; Kuroda Y; Ito S; Eguchi H; Saeki H; Oki E; Maehara Y; Mimori K
    Ann Surg Oncol; 2018 Mar; 25(3):745-753. PubMed ID: 29270876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arl4c expression in colorectal and lung cancers promotes tumorigenesis and may represent a novel therapeutic target.
    Fujii S; Matsumoto S; Nojima S; Morii E; Kikuchi A
    Oncogene; 2015 Sep; 34(37):4834-44. PubMed ID: 25486429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a Tumor Microenvironment-relevant Gene set-based Prognostic Signature and Related Therapy Targets in Gastric Cancer.
    Cai WY; Dong ZN; Fu XT; Lin LY; Wang L; Ye GD; Luo QC; Chen YC
    Theranostics; 2020; 10(19):8633-8647. PubMed ID: 32754268
    [No Abstract]   [Full Text] [Related]  

  • 5. MiR-181a, a new regulator of TGF-β signaling, can promote cell migration and proliferation in gastric cancer.
    Ge S; Zhang H; Deng T; Sun W; Ning T; Fan Q; Wang Y; Wang X; Zhang Q; Zhou Z; Yang H; Ying G; Ba Y
    Invest New Drugs; 2019 Oct; 37(5):923-934. PubMed ID: 30607520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Relations of transforming growth factor-beta1 expression to differentiation and prognosis of advanced gastric cancer].
    Guo RF; Zang SZ; Zhang L; Li WM; Hu FL; Lü YY
    Zhonghua Yi Xue Za Zhi; 2006 Dec; 86(46):3249-54. PubMed ID: 17313802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ADP-ribosylation factor-like 4C predicts worse prognosis in endometriosis-associated ovarian cancers.
    Wakinoue S; Chano T; Amano T; Isono T; Kimura F; Kushima R; Murakami T
    Cancer Biomark; 2019; 24(2):223-229. PubMed ID: 30594917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circular RNA hsa_circ_0004872 inhibits gastric cancer progression via the miR-224/Smad4/ADAR1 successive regulatory circuit.
    Ma C; Wang X; Yang F; Zang Y; Liu J; Wang X; Xu X; Li W; Jia J; Liu Z
    Mol Cancer; 2020 Nov; 19(1):157. PubMed ID: 33172486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-302s Might Regulate ARL4C-Mediated Gastric Cancer Progression via p53 Signaling: Bioinformatics Analysis and Experiments Validation.
    Xie N; Pan Y; Wu J; Bai Y; Xiao C; Gao X; Wang J; Liu N
    Onco Targets Ther; 2021; 14():2541-2553. PubMed ID: 33880033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of TRPV1 ion channels in the suppression of gastric cancer development.
    Gao N; Yang F; Chen S; Wan H; Zhao X; Dong H
    J Exp Clin Cancer Res; 2020 Oct; 39(1):206. PubMed ID: 33008449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lysine-222 succinylation reduces lysosomal degradation of lactate dehydrogenase a and is increased in gastric cancer.
    Li X; Zhang C; Zhao T; Su Z; Li M; Hu J; Wen J; Shen J; Wang C; Pan J; Mu X; Ling T; Li Y; Wen H; Zhang X; You Q
    J Exp Clin Cancer Res; 2020 Aug; 39(1):172. PubMed ID: 32859246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical relevance of ARF/ARL family genes and oncogenic function of ARL4C in endometrial cancer.
    Zhang J; Zhang Q; Sun C; Huang Y; Zhang J; Wang Q
    Biomed Pharmacother; 2020 May; 125():110000. PubMed ID: 32070877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Knockdown of linc00152 inhibits the progression of gastric cancer by regulating microRNA-193b-3p/ETS1 axis.
    Wang H; Chen W; Yang P; Zhou J; Wang K; Tao Q
    Cancer Biol Ther; 2019; 20(4):461-473. PubMed ID: 30404587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and prognostic significance of Arl4c expression in colorectal cancer.
    Chen X; Su Z; Wang S; Xu H
    Cancer Biomark; 2016; 16(2):253-7. PubMed ID: 26756615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A-kinase-interacting protein 1 facilitates growth and metastasis of gastric cancer cells via Slug-induced epithelial-mesenchymal transition.
    Chen D; Cao G; Liu Q
    J Cell Mol Med; 2019 Jun; 23(6):4434-4442. PubMed ID: 31020809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CXCR4/TGF-β1 mediated hepatic stellate cells differentiation into carcinoma-associated fibroblasts and promoted liver metastasis of colon cancer.
    Tan HX; Gong WZ; Zhou K; Xiao ZG; Hou FT; Huang T; Zhang L; Dong HY; Zhang WL; Liu Y; Huang ZC
    Cancer Biol Ther; 2020; 21(3):258-268. PubMed ID: 31825725
    [No Abstract]   [Full Text] [Related]  

  • 17. Localization of KRAS downstream target ARL4C to invasive pseudopods accelerates pancreatic cancer cell invasion.
    Harada A; Matsumoto S; Yasumizu Y; Shojima K; Akama T; Eguchi H; Kikuchi A
    Elife; 2021 Sep; 10():. PubMed ID: 34590580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive evaluation of FKBP10 expression and its prognostic potential in gastric cancer.
    Liang L; Zhao K; Zhu JH; Chen G; Qin XG; Chen JQ
    Oncol Rep; 2019 Aug; 42(2):615-628. PubMed ID: 31233188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. XIST promotes gastric cancer (GC) progression through TGF-β1 via targeting miR-185.
    Zhang Q; Chen B; Liu P; Yang J
    J Cell Biochem; 2018 Mar; 119(3):2787-2796. PubMed ID: 29053187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ARL4C stabilized by AKT/mTOR pathway promotes the invasion of PTEN-deficient primary human glioblastoma.
    Chen Q; Weng HY; Tang XP; Lin Y; Yuan Y; Li Q; Tang Z; Wu HB; Yang S; Li Y; Zhao XL; Fu WJ; Niu Q; Feng H; Zhang X; Wang Y; Bian XW; Yao XH
    J Pathol; 2019 Feb; 247(2):266-278. PubMed ID: 30357833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.